This inventor holds 2 USPTO granted patents and 1 EPO patent. Top assignee: Asd Therapeutics Partners, LLC. Active years: 2016.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2016
Title: Susana Herrero Santos: Innovator in Pharmaceutical Research
Introduction
Susana Herrero Santos is a prominent inventor based in Tres Cantos-Madrid, Spain. She has made significant contributions to the field of pharmaceutical research, particularly in the development of innovative compounds for treating various diseases. With a total of 2 patents, her work focuses on addressing critical health challenges.
Latest Patents
One of her latest patents involves the use of thiadiazolidinediones as GSK-3 inhibitors. This invention relates to new thiadiazolidinediones of formula (I), or any pharmaceutically acceptable salt, solvate, or prodrug thereof. The patent highlights their application in treating diseases where glycogen synthase kinase 3 (GSK-3) is implicated, especially neurodegenerative diseases, inflammatory and autoimmune diseases, and cardiovascular disorders. Additionally, the patent provides a process for preparing such compounds, along with pharmaceutical compositions that include them.
Career Highlights
Susana is currently associated with Asd Therapeutics Partners, LLC, where she continues to advance her research and development efforts. Her innovative approach and dedication to improving health outcomes have positioned her as a key figure in her field.
Collaborations
Throughout her career, Susana has collaborated with notable professionals, including Miguel Medina Padilla and Juan Manuel Domínguez Correa. These partnerships have further enriched her research and contributed to her success as an inventor.
Conclusion
Susana Herrero Santos exemplifies the spirit of innovation in pharmaceutical research. Her contributions through her patents and collaborations are paving the way for new treatments that can significantly impact patient care.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile